Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
In the recent phase III trial MPACT the combination of gemcitabine and nab-paclitaxel (Gem/NabP) showed increased overall survival compared to gemcitabine alone in the treatment of advanced pancreatic ductal adenocarcinoma (aPDA). | Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer